Your Seven Day Forecast

McEachin Votes to Keep the Government Open

House Passes Continuing Appropriations and Ukraine Supplemental Appropriations Act to Fund the Federal Government

Washington, D.C. – On Friday, Congressman A. Donald McEachin (VA-04) helped pass the Senate Amendment to H.R. 6833, the Continuing Appropriations and Ukraine Supplemental Appropriations Act, to continue government funding through December 16, 2022. The CR extends funding for vital federal agencies, including education, health, housing, and public safety programs to allow Congress time to complete its work on Fiscal Year 2023.

“It is imperative that our government remains open and working for the American people, which is why I voted for today’s stopgap funding measure,” said Rep. McEachin (VA-04). “Not only does this bill fund our federal government, it includes important provisions to help hardworking Virginians with rising costs. Furthermore, this legislation provides necessary resources to help communities impacted from recent natural disasters and additional assistance to support the Ukrainian people, as Russia continues its aggressions. During this extension, we will continue working to advance all the necessary appropriations bills to fully fund our government for the coming fiscal year.”

The Continuing Appropriations and Ukraine Supplemental Appropriations Act includes:

  • Billions in relief for New Mexico, Puerto Rico, Florida, Alaska and other communities hit by natural disasters, especially in the wake of Hurricane Ian
  • $12.3 billion to power the fight for freedom in Ukraine, including new security, economic and humanitarian assistance
  • More resources to respond to the water crisis in Jackson, Mississippi: an emergency that poses a direct threat to the health and well-being of Mississippi families
  • Bolstering funding for the Low-Income Home Energy Assistance Program: this will help working families pay for higher energy bills as we enter the winter months
  • Five-year reauthorization of FDA user fees: ensuring no interruption to the FDA’s life-saving work reviewing and approving new prescription drugs coming to market
  • More resources to continue resettling brave Afghan evacuees

Read the one-page fact sheet here and the section-by-section summary here.